Myomo, Inc.
$1.31
The Read: Myomo’s stock fell about 19% after Q4 2025 as widening losses and dilution fears overshadowed a multi-state Elevance Health deal, but then rose about 10.
Price
Overlays
Panel
MYO
Hover to view data
No Data
By creating an account you agree to our Terms of Service and Privacy Policy.
$1.31
The Read: Myomo’s stock fell about 19% after Q4 2025 as widening losses and dilution fears overshadowed a multi-state Elevance Health deal, but then rose about 10.
No Data